Clinical Trials
29 trialsEfficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection
Ningbo No.2 Hospital
STOPHCC-GAAD
Siriraj Hospital
Effect of Babao Dan Capsule Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis
Nanfang Hospital, Southern Medical University
Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study
Nanfang Hospital, Southern Medical University
VIGILANT
Imperial College London
Observation Study on Reducing the Risk of Liver Cancer Associated With Hepatitis B (Zhiyuan) Project.
The First Affiliated Hospital of Zhengzhou University
PRTRAS 001
Shenzhen Third People's Hospital
HBV-Biomark
Assistance Publique - Hôpitaux de Paris
Durvalumab for Advanced Hepatocellular Carcinoma in Patients With Active Chronic Hepatitis B Virus Infection
National Taiwan University Hospital
Cameroon Baptist Convention Health Board Chronic Hepatitis B Cohort Study
Mayo Clinic
A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients
Ruijin Hospital
dSEARCH
Ruijin Hospital
Study on Screening, Verification and Intervention of High-risk Patients With Liver Cancer
Zhongshan Hospital (Xiamen), Fudan University
PILOT
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
WATCH
Imperial College London
A Cohort Study on Long-term Clinical Outcomes of Antiviral Therapy in Patients With Chronic Hepatitis B and Cirrhosis
Beijing Ditan Hospital
Prophylaxis of CHB Patients With Malignant Tumor Receiving Chemotherapy
Chang Gung Memorial Hospital
Risk of Hepatocellular Carcinoma in Patients Treated With ETV vs TDF for Chronic Hepatitis B With Compensated Cirrhosis
Ruijin Hospital
Biologic Basis of Liver Cancer From Chronic Hepatitis B
University of California, Davis
The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC)
Seoul National University Hospital
Efficacy and Safety of Ibrutinib in Patients With CLL and Other Indolent B-cell Lymphomas Who Are Chronic Hepatitis B Virus Carriers or Occult Hepatitis B Virus Carriers
The University of Hong Kong
The Investigation of Peginterferon Alfa-2a on the RFS of the Subjects With HCC Who Have Been Treated by Resection
Huashan Hospital
Follow-up Strategy of Chronic Hepatitis B for Early Detection and Diagnosis of Hepatocellular Carcinoma: A Randomized Control Trial
Third Affiliated Hospital, Sun Yat-Sen University
VDHCC
Third Affiliated Hospital, Sun Yat-Sen University
ROLFH
University of Arkansas
Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma
Taichung Veterans General Hospital
Assessment of Hepatitis B Virus Intra-host Population and Host-specific Immune Marker Diversity
Universitaire Ziekenhuizen KU Leuven
Hepatitis B Virus Reactivation After Withdrawal of Preemptive Antiviral Therapy in Hematologic Malignancy
Seoul St. Mary's Hospital
PICTURE
Kindai University